NOBEL BIOCARE DANMARK A/S: Financial statements 2023
CVR: 28293364
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,122,730 and a net result of DKK -2,013,483 compared with DKK -488,865 the year before. That is a decrease of 6.5% compared with the year before. Equity in the 2023 report amounted to DKK -1,644,237. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,122,730
- Profit/Loss
- DKK -2,013,483
- Equity
- DKK -1,644,237
- Total Assets
- DKK 154,529,240
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3.1M | -2M | -1.6M | 4 |
| 2022 | - | 3.3M | -489K | 369K | 3 |
| 2021 | - | 4.3M | 268K | 858K | 3 |
| 2020 | - | 4.8M | -794K | -1.4M | 5 |
| 2019 | - | 4M | -5.5M | -616K | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NOBEL BIOCARE DANMARK A/S has published its annual report for 2022. Gross profit came to DKK 3,338,235, and the net result was DKK -488,865.
As of January 16, 2023, Stefan Fabian Lieb has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 16, 2023, Stefan Fabian Lieb is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2023, Chris James Stahle has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of January 15, 2023, Chris James Stahle has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.